Key Findings

The study shows that mutations in gyrB and eis genes improve the detection of second-line drug resistance in Mycobacterium tuberculosis isolates. Specifically, gyrB mutations enhance the detection of ofloxacin resistance, while the eis C-14T mutation improves the detection of kanamycin resistance.